[1] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48. DOI: 10.3322/caac.21763.
|
[2] |
段帅, 郭晨明, 李慧芳, 等. 1990—2019年中国女性乳腺癌发病死亡趋势及年龄-时期-队列模型分析[J]. 国际肿瘤学杂志, 2022, 49(10): 586-591. DOI: 10.3760/cma.j.cn371439-20220726-00116.
|
[3] |
Wang X, Jing L, Yan L, et al. A conditional inference tree model for predicting cancer risk of non-mass lesions detected on breast ultrasound[J]. Eur Radiol, 2024, 34(7): 4776-4788. DOI: 10.1007/s00330-023-10504-7.
|
[4] |
Golatta M, Pfob A, Büsch C, et al. The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics—an international, multicentre trial[J]. Eur J Cancer, 2022, 161: 1-9. DOI: 10.1016/j.ejca.2021.11.005.
|
[5] |
Qu XX, Song Y, Zhang YH, et al. Value of ultrasonic elastography and conventional ultrasonography in the differential diagnosis of non-mass-like breast lesions[J]. Ultrasound Med Biol, 2019, 45(6): 1358-1366. DOI: 10.1016/j.ultrasmedbio.2019.01.020.
|
[6] |
于鹏丽, 孔文韬, 薛海燕, 等. 声触诊组织成像量化技术鉴别诊断非肿块型乳腺病变良恶性的临床价值[J]. 肿瘤影像学, 2022, 31(6): 575-580. DOI: 10.19732/j.cnki.2096-6210.2022.06.003.
|
[7] |
Mannu GS, Wang Z, Broggio J, et al. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988—2014: population based observational cohort study[J]. BMJ, 2020, 369: m1570. DOI: 10.1136/bmj.m1570.
|
[8] |
Marino MA, Avendano D, Zapata P, et al. Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools[J]. Oncologist, 2020, 25(2): e231-e242. DOI: 10.1634/theoncologist.2019-0427.
|
[9] |
Park KW, Park S, Shon I, et al. Non-mass lesions detected by breast US: stratification of cancer risk for clinical management[J]. Eur Radiol, 2021, 31(3): 1693-1706. DOI: 10.1007/s00330-020-07168-y.
|
[10] |
Guo W, Wang T, Li F, et al. Non-mass breast lesions: could multimodal ultrasound imaging be helpful for their diagnosis?[J]. Diagnostics (Basel), 2022, 12(12): 2923. DOI: 10.3390/diagnostics12122923.
|
[11] |
Zhang F, Wang J, Jin L, et al. Comparison of the diagnostic value of contrast-enhanced ultrasound combined with conventional ultrasound versus magnetic resonance imaging in malignant non-mass breast lesions[J]. Br J Radiol, 2023, 96(1150): 20220880. DOI: 10.1259/bjr.20220880.
|
[12] |
Cutuli B. Ductal carcinoma in situ in 2019: diagnosis, treatment, prognosis[J]. Presse Med, 2019, 48(10): 1112-1122. DOI: 10.1016/j.lpm.2019.08.018.
|
[13] |
Badve SS, Gökmen-Polar Y. Ductal carcinoma in situ of breast: update 2019[J]. Pathology, 2019, 51(6): 563-569. DOI: 10.1016/j.pathol.2019.07.005.
|
[14] |
Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(6): 691-722. DOI: 10.6004/jnccn.2022.0030.
|
[15] |
中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J]. 中国癌症杂志, 2023, 33(12): 1092-1186. DOI: 10.19401/j.cnki.1007-3639.2023.12.004.
|
[16] |
Luo R, Zhang Y, Jiang W, et al. Value of micro-flow imaging and high-definition micro-flow imaging in differentiating malignant and benign breast lesions[J]. Clin Radiol, 2024, 79(1): e48-e56. DOI: 10.1016/j.crad.2023.10.007.
|
[17] |
Bartolotta TV, Orlando AAM, Schillaci MI, et al. Ultrasonographic detection of vascularity of focal breast lesions: microvascular imaging versus conventional color and power doppler imaging[J]. Ultrason Imaging, 2021, 43(5): 273-281. DOI: 10.1177/01617346211029542.
|
[18] |
Aladag Kurt S, Kayadibi Y, Onur I, et al. Predicting axillary nodal metastasis based on the side of asymmetrical cortical thickening in breast cancer: evaluation with grayscale and microvascular imaging findings[J]. Eur J Radiol, 2023, 158: 110643. DOI: 10.1016/j.ejrad.2022.110643.
|
[19] |
Zhang P, Kong P, Liu D, et al. Non-mass-type ductal carcinoma in situ of the breast on ultrasound: features and pathological analysis[J]. J Cancer Res Ther, 2024, 20(2): 665-668. DOI: 10.4103/jcrt.jcrt_2251_23.
pmid: 38687938
|